Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Lymphatic Research and Biology|September 26, 2009
A novel tool for intralymphatic injection: the modified glass hypodermic needleD Chubb, W M Rozen, W-R Pan
Diabetic Medicine : a Journal of the British Diabetic Association|August 8, 2015
Hypoglycaemia in adults with insulin-treated diabetes in the UK: self-reported frequency and effectsB M Frier, M M Jensen, B D Chubb
Clinical Science (London, England : 1979)|January 1, 1988
The effect of ketone bodies on leucine and alanine metabolism in dogsA M Umpleby, D Chubb, M A Boroujerdi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 3, 2011
Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitusM J Davies, B D Chubb, I C Smith, et al.
Toxicology|February 1, 1985
Studies on the toxicity of the antitumour agent N-methylformamide in miceS P Langdon, D Chubb, A Gescher, et al.
The Journal of Arthroplasty|March 10, 2022
John N. Insall Award: MARCQI's Pain-Control Optimization Pathway (POP): Impact of Registry Data and Education on Opioid UtilizationJames T Layson, David C Markel, Richard E Hughes, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1985
N-Methylformamide (NSC 3051): a potential candidate for combination chemotherapyS P Langdon, J A Hickman, A Gescher, et al.
The Journal of Arthroplasty|February 24, 2023
A Reduction in Opioid Prescription Size After Total Joint Arthroplasty Can be Safely Performed Without an Increase in ComplicationsThomas S Wenzlick, Andrew R Kutzner, David C Markel, et al.
Journal of Medicinal Chemistry|June 1, 1986
Structural studies on bioactive compounds. 4. A structure-antitumor activity study on analogues of N-methylformamideE N Gate, M D Threadgill, M F Stevens, et al.
Cancer Research|November 15, 1987
Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazineM F Stevens, J A Hickman, S P Langdon, et al.
Pageof 2